CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest

[1]  F. Yang,et al.  A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth , 2014, Oncogene.

[2]  G. Ren,et al.  Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy. , 2014, Immunology letters.

[3]  E. Sitnicka,et al.  NK cell development and function--plasticity and redundancy unleashed. , 2014, Seminars in immunology.

[4]  B. Lambrecht,et al.  Sustained stimulation and expansion of Tregs by IL2 control autoimmunity without impairing immune responses to infection, vaccination and cancer. , 2014, Clinical immunology.

[5]  Su-zhan Zhang,et al.  Cytohesins/ARNO: The Function in Colorectal Cancer Cells , 2014, PloS one.

[6]  M. Clément,et al.  CD31 is a key coinhibitory receptor in the development of immunogenic dendritic cells , 2014, Proceedings of the National Academy of Sciences.

[7]  S. Tejpar,et al.  EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab , 2014, Journal of Cancer Research and Clinical Oncology.

[8]  R. Bertorelle,et al.  Telomeres, telomerase and colorectal cancer. , 2014, World journal of gastroenterology.

[9]  B. A. Shah,et al.  Genetic unraveling of colorectal cancer , 2014, Tumor Biology.

[10]  Amit Bar-Or,et al.  IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases , 2014, Nature.

[11]  Yufeng Xie,et al.  Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy , 2014, Melanoma research.

[12]  Do-Hyun Kim,et al.  Insights into the Role of Follicular Helper T Cells in Autoimmunity , 2014, Immune network.

[13]  B. Kirkham,et al.  Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis , 2014, Immunology.

[14]  F. Coppedè,et al.  Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. , 2014, World journal of gastroenterology.

[15]  W. Zhou,et al.  Gli1 inhibition suppressed cell growth and cell cycle progression and induced apoptosis as well as autophagy depending on ERK1/2 activity in human chondrosarcoma cells , 2014, Cell Death and Disease.

[16]  Yeul-Hong Kim,et al.  Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients? , 2014, Cancer research and treatment : official journal of Korean Cancer Association.

[17]  J. Ji,et al.  CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer , 2013, Cancer Science.

[18]  J. Douillard,et al.  RAS mutations in colorectal cancer. , 2013, The New England journal of medicine.

[19]  Francesca Molinari,et al.  Functions and Regulation of the PTEN Gene in Colorectal Cancer , 2013, Front. Oncol..

[20]  A. Mercurio,et al.  VEGF targets the tumour cell , 2013, Nature Reviews Cancer.

[21]  C. Gu,et al.  IL-17 family: cytokines, receptors and signaling. , 2013, Cytokine.

[22]  Songbing He,et al.  Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistantgastric cancer cells to cisplatin. , 2013, Oncology reports.

[23]  T. Handel,et al.  The Chemokine Receptor CCR1 Is Constitutively Active, Which Leads to G Protein-independent, β-Arrestin-mediated Internalization* , 2013, The Journal of Biological Chemistry.

[24]  V. Besada,et al.  The Trypsin Inhibitor Panulirin Regulates the Prophenoloxidase-activating System in the Spiny Lobster Panulirus argus , 2013, The Journal of Biological Chemistry.

[25]  J. Tabernero,et al.  Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. , 2013, The New England journal of medicine.

[26]  N. Neamati,et al.  Stabilization of MDA-7/IL-24 for colon cancer therapy. , 2013, Cancer letters.

[27]  J. Inoue,et al.  Intracellular Delivery of Lipopolysaccharide Induces Effective Th1-Immune Responses Independent of IL-12 , 2013, PloS one.

[28]  Karl J. Dykema,et al.  Overexpression of HGF Promotes HBV-Induced Hepatocellular Carcinoma Progression and Is an Effective Indicator for Met-Targeting Therapy , 2013, Genes & cancer.

[29]  Kebin Liu,et al.  Epigenetics and Colorectal Cancer Pathogenesis , 2013, Cancers.

[30]  M. Grano,et al.  Cellular Mechanisms of Multiple Myeloma Bone Disease , 2013, Clinical & developmental immunology.

[31]  L. Sigal,et al.  Immunology: Memory cells sound the alarm , 2013, Nature.

[32]  B. Cairns,et al.  Epigenetic regulation of colon cancer and intestinal stem cells. , 2013, Current opinion in cell biology.

[33]  M. Arends.  Pathways of Colorectal Carcinogenesis , 2013, Applied immunohistochemistry & molecular morphology : AIMM.

[34]  S. Seys,et al.  IL-17A in Human Respiratory Diseases: Innate or Adaptive Immunity? Clinical Implications , 2013, Clinical & developmental immunology.

[35]  O. Lee,et al.  Oncostatin m modulates the mesenchymal-epithelial transition of lung adenocarcinoma cells by a mesenchymal stem cell-mediated paracrine effect. , 2012, Cancer research.

[36]  Rick L. Evans,et al.  Multiple Functions of Sushi Domain Containing 2 (SUSD2) in Breast Tumorigenesis , 2012, Molecular Cancer Research.

[37]  Ting Li,et al.  VSTM1-v2, a novel soluble glycoprotein, promotes the differentiation and activation of Th17 cells. , 2012, Cellular immunology.

[38]  O. Briz,et al.  Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer , 2012, Drug metabolism reviews.

[39]  E. Chu,et al.  Can metastatic colorectal cancer be cured? , 2012, Oncology.

[40]  Ming-Daw Tsai,et al.  Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. , 2011, Biochemistry.

[41]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[42]  J. Roth,et al.  Adenovirus-mediated interleukin (IL)-24 immunotherapy for cancer. , 2010, Methods in molecular biology.

[43]  Li Li,et al.  A mouse knockout library for secreted and transmembrane proteins , 2010, Nature Biotechnology.

[44]  T. Nagykálnai,et al.  [Chemotherapy of elderly patients with colorectal cancer]. , 2009, Magyar onkologia.

[45]  Y. Hayashizaki,et al.  Isolation of a novel mouse gene, mSVS‐1/SUSD2, reversing tumorigenic phenotypes of cancer cells in vitro , 2007, Cancer science.

[46]  Y. Okazaki,et al.  von Willebrand factor type D domain mutant of SVS‐1/SUSD2, vWDm, induces apoptosis in HeLa cells , 2007 .

[47]  M. Moran,et al.  Large-scale mapping of human protein–protein interactions by mass spectrometry , 2007, Molecular systems biology.

[48]  J. Massagué,et al.  G1 cell-cycle control and cancer , 2004, Nature.

[49]  Wenfeng Xu,et al.  Cytokine–receptor pairing: accelerating discovery of cytokine function , 2004, Nature Reviews Drug Discovery.

[50]  J. Ziebuhr,et al.  The 3C-Like Proteinase of an Invertebrate Nidovirus Links Coronavirus and Potyvirus Homologs , 2003, Journal of Virology.

[51]  R. Joubert‐Caron,et al.  Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36 , 2001, Cancer Cell International.

[52]  L. Wang,et al.  Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. , 2001, The Biochemical journal.

[53]  M. Serrano.  The tumor suppressor protein p16INK4a. , 1997, Experimental cell research.

[54]  L. Carnell,et al.  Post-Golgi membrane traffic: brefeldin A inhibits export from distal Golgi compartments to the cell surface but not recycling , 1992, The Journal of cell biology.

[55]  M. Kozak.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. , 1987, Nucleic acids research.

[56]  Guoqing Wang,et al.  Gene expression profile based classification models of psoriasis. , 2014, Genomics.

[57]  J. Jolkkonen,et al.  Stromal cell-derived factor-1 and its receptor CXCR4 in adult neurogenesis after cerebral ischemia. , 2013, Restorative neurology and neuroscience.

[58]  Fabio Beltram,et al.  Quantitative FRET Analysis With the E0GFP‐mCherry Fluorescent Protein Pair , 2009, Photochemistry and photobiology.

[59]  Y. Okazaki,et al.  von Willebrand factor type D domain mutant of SVS-1/SUSD2, vWD(m), induces apoptosis in HeLa cells. , 2007, Cancer science.

[60]  K. P. Murphy,et al.  Janeway's immunobiology , 2007 .

[61]  S. Hsu,et al.  Autocrine and paracrine functions of cytokines in malignant lymphomas. , 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.